People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MicroVascular Tissues, Inc. | — | Other Health Care | Series A | $11.9M | $32.1M | 2023 |
| Mussel Polymers, Inc. | — | Biotechnology | Series A | $4.8M | $12.3M | 2025 |
Kevin Ohashi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Ohashi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Anderson | 1 | 11 |
| George Boyajian | 1 | 3 |
| Dale Peterson | 1 | 3 |
| Kevin L Ohashi | 1 | 2 |
| Dale R. Peterson | 1 | 1 |
| Brent L. Atkinson | 1 | 1 |
| Glen Gong | 1 | 1 |
| Kevin L. Oshasi | 1 | 1 |
| Dale L Peterson | 1 | 1 |
| Glen G. Gong | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.